The ongoing tensions between Iran, Israel, and the United States are now starting to affect India’s healthcare sector. Drug manufacturers in India say they are facing problems like supply chain disruptions, rising costs of raw materials, and increasing pressure on the pharmaceutical industry.
Companies are warning that if the situation continues, patients may soon feel the impact. There could be shortages of medicines, delays in availability, and even higher prices for common drugs.
The main concern is about essential medicines that people use every day. These include medicines for fever, infections, diabetes, and heart diseases. Industry experts say that if companies find it difficult to continue production due to high costs, it may become harder for patients to get these basic treatments.
The conflict in the Middle East is also affecting transportation and supply routes, which is adding to the problem. Delays in shipments and increased costs of importing raw materials are making it more challenging for drugmakers to maintain steady production.
Overall, if the situation does not improve soon, it could create serious challenges for both the pharmaceutical industry and patients in India, especially those who depend on regular medication.